Reuters UK Business

Mediobanca investor Delfin will keep assessing ‘very interesting’ Monte Paschi bid, chairman tells paper

ROME (Reuters) -Mediobanca’s biggest investor, Delfin, will continue to assess Monte dei Paschi’s “very interesting” offer for the merchant bank, the chairman of the holding said on Tuesday. “Any possible adjustment in the bid which will reflect Mediobanca’s market price would make the offer more attractive for investors,” Francesco Milleri said in an interview with …

Mediobanca investor Delfin will keep assessing ‘very interesting’ Monte Paschi bid, chairman tells paper Read More »

Baker Hughes nears $13.6 billion deal to buy Chart, edging out Flowserve, FT reports

(Reuters) -Oil and gas equipment supplier Baker Hughes is nearing a $13.6 billion cash deal to buy Chart Industries, edging out rival suitor Flowserve, with a buyout likely to be announced in the coming days, the Financial Times reported on Monday, citing sources who warned that the agreement was not final. Baker Hughes has been …

Baker Hughes nears $13.6 billion deal to buy Chart, edging out Flowserve, FT reports Read More »

Vitol paid out $10.6 billion to shareholders in buybacks in 2024

LONDON (Reuters) -Global commodity trading house Vitol Group paid $10.6 billion to employees who own shares in the company, through its annual share buyback scheme in 2024, company filings seen by Reuters showed. Vitol’s $10.6 billion in buyback payments were up from the $6.4 billion it paid in 2023 – extending its highest ever. Buybacks …

Vitol paid out $10.6 billion to shareholders in buybacks in 2024 Read More »

EU-US trade deal could add up to $19 billion in pharma industry costs, analysts say

By Bhanvi Satija (Reuters) -The European Union’s trade deal with the United States could cost the pharmaceutical industry between $13 billion and $19 billion as branded medicines become subject to a tariff of 15%, analysts said on Monday.  The added costs could raise prices for consumers unless pharmaceutical companies take action to mitigate the impact …

EU-US trade deal could add up to $19 billion in pharma industry costs, analysts say Read More »

UK’s Wise shareholders approve move to US stock exchange

(Reuters) -Shareholders of British fintech Wise Plc on Monday approved plans to shift the company’s primary stock market listing to the U.S. from the London Stock Exchange. The shareholders’ vote at an extraordinary general meeting clears a key hurdle in Wise’s plan to pursue a U.S. primary listing, which will improve its access to capital …

UK’s Wise shareholders approve move to US stock exchange Read More »

Serbia secures fifth postponement of US sanctions against NIS oil firm

BELGRADE (Reuters) -Serbia has secured a fifth postponement of planned U.S. sanctions against Russian-owned oil firm NIS, which operates the country’s only oil refinery, Serbian Energy Minister Dubravka Djedovic Handanovic said on Monday. The postponement would be a month long,  and a longer extension was not possible, she said in a written statement. “Our top …

Serbia secures fifth postponement of US sanctions against NIS oil firm Read More »

Exclusive-Buyout groups explore sale of British wealth manager Evelyn, sources say

By Amy-Jo Crowley and Charlie Conchie LONDON (Reuters) -Private equity firms Permira and Warburg Pincus are exploring the possible sale of Evelyn Partners, one of the UK’s largest wealth managers, three sources with knowledge of the matter said. The owners are working with advisers to prepare for a potential sale of the London-based business towards …

Exclusive-Buyout groups explore sale of British wealth manager Evelyn, sources say Read More »

Heineken shares slide as tariff uncertainties spook investors

By Emma Rumney LONDON (Reuters) -Dutch brewer Heineken’s <HEIN.AS> shares slid over 8% on Monday as a forecast-beating profit rise was eclipsed by investor worries over second-half profits and volumes, which Heineken warned may be softer as tariffs weigh on confidence. The world’s No.2 brewer welcomed a trade deal struck between the European Union and …

Heineken shares slide as tariff uncertainties spook investors Read More »

Cycling-Wiebes wins chaotic sprint in Tour de France Femmes stage three as Vos reclaims yellow

(Reuters) -Lorena Wiebes prevailed in a chaotic sprint to claim victory in the third stage of the Tour de France Femmes on Monday, edging fellow Dutch rider Marianne Vos who took the overall lead after a 163.5km ride from La Gacilly to Angers. Sprint specialist Wiebes (SD Worx-Protime), who narrowly lost stage two to Mavi …

Cycling-Wiebes wins chaotic sprint in Tour de France Femmes stage three as Vos reclaims yellow Read More »

Close Bitnami banner
Bitnami